Pompidou Group – Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs
17 Mar 2020 14:32:00
European Court of Human Rights says depriving mother with drug addiction of her parental rights was disproportionateStrasbourg 25 February 2020
In its judgment of 25 February 2020 in the case of Y.I. v. Russia, the European Court of Human...
05 Mar 2020 09:18:00Vienna, Austria 2-6 March 2020
As in previous years, the Pompidou Group took part in the yearly session (Vienna, 2-6 March 2020)...
05 Mar 2020 09:13:00Tbilsi, Georgia 18-19 February 2020
This topic was at the heart of intensive discussions and inspiring talks by speakers from...
04 Mar 2020 14:47:00Minsk, Belarus 18-19 february 2020
At its launching meeting in Minsk on 18-19 February 2020, Pompidou Group discussed activities for...
10 Jan 2020 09:19:001 January 2020
2020 begins with good news : Armenia has decided to join the Pompidou Group as of 1 January, thus...
Learn about the Pompidou Group's approach on bringing Human Rights to the forefront of drug policy
There is a need to have processes in place for on-going assessment to ensure that human rights are and remain respected and safeguarded. Policy makers, policy implementers and policy evaluators must be aware and mindful of the human rights dimension that should inspire their choices and decisions. The Pompidou Group stresses this need in its 2017 statement on bringing human rights into drug policy. The statement confirms the member states’ categorical opposition to the death penalty and condemns extrajudicial executions, arbitrary detention and inhuman or degrading treatment or punishment. Member states also express their commitment to good democratic governance principles and to reducing the stigma of drug users, and acknowledge indicators that can be relied upon when conducting a human rights-based review of drug policy.
- Statement on bringing human rights into drug policy development, implementation, monitoring and evaluation
- Background paper ‘Drug policy and Human Rights in Europe: Managing tensions, maximizing complementarities’
- Statement on costs and spill-over consequences of drug policies
Approximately 60-70% of the general population experience a traumatic event at some point in their lifetime, which can include forms of violence, abuse, neglect and war. Post-Traumatic Stress Disorder (PTSD) and Substance Use Disorders (SUD) are often concurrent and develop as a result of a person being exposed to a traumatic event.
Therefore, part of providing adequate health service is responding correctly to the effects of trauma.
The latest Pompidou Group paper addresses this issue, by providing guidance on psychosocial support to tackle trauma-related symptoms and related substance use disorders, in particular among refugees, internally displaced persons and war veterans as groups especially vulnerable to PTSD.